NCT00502853View on ClinicalTrials.gov

A Pilot Study of MabThera (Rituximab) Evaluated by MRI in Patients With Rheumatoid Arthritis.

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 25, 2007

Primary Completion Date

July 23, 2010

Study Completion Date

July 23, 2010

Conditions
Rheumatoid Arthritis
Interventions
DRUG

rituximab [MabThera/Rituxan]

1000mg iv on days 1 and 15

DRUG

Methotrexate

10-25mg/week

Trial Locations (1)

16132

Università Degli Studi Di Genova - Dimi; Reumatologia, Genoa

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT00502853 - A Pilot Study of MabThera (Rituximab) Evaluated by MRI in Patients With Rheumatoid Arthritis. | Biotech Hunter | Biotech Hunter